ATE484576T1 - Chimäre bauchspeicheldrüse - Google Patents

Chimäre bauchspeicheldrüse

Info

Publication number
ATE484576T1
ATE484576T1 AT03745590T AT03745590T ATE484576T1 AT E484576 T1 ATE484576 T1 AT E484576T1 AT 03745590 T AT03745590 T AT 03745590T AT 03745590 T AT03745590 T AT 03745590T AT E484576 T1 ATE484576 T1 AT E484576T1
Authority
AT
Austria
Prior art keywords
recipient
mammalian
pancreatic
tissue
pancreatic tissue
Prior art date
Application number
AT03745590T
Other languages
English (en)
Inventor
Marc Hammerman
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE484576T1 publication Critical patent/ATE484576T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2806—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/289—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD45
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03745590T 2002-03-25 2003-03-24 Chimäre bauchspeicheldrüse ATE484576T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36718102P 2002-03-25 2002-03-25
PCT/US2003/009091 WO2003083064A2 (en) 2002-03-25 2003-03-24 Chimeric pancreas

Publications (1)

Publication Number Publication Date
ATE484576T1 true ATE484576T1 (de) 2010-10-15

Family

ID=28675331

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03745590T ATE484576T1 (de) 2002-03-25 2003-03-24 Chimäre bauchspeicheldrüse

Country Status (16)

Country Link
US (2) US7384630B2 (de)
EP (1) EP1487967B1 (de)
JP (1) JP2005521497A (de)
KR (1) KR20040099350A (de)
CN (1) CN1643133A (de)
AT (1) ATE484576T1 (de)
AU (1) AU2003259298B2 (de)
BR (1) BR0308718A (de)
CA (1) CA2477538C (de)
DE (1) DE60334534D1 (de)
EA (1) EA200401244A1 (de)
IL (1) IL164250A0 (de)
MX (1) MXPA04009411A (de)
NO (1) NO20044540L (de)
WO (1) WO2003083064A2 (de)
ZA (1) ZA200406983B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL165425A0 (en) * 2004-11-28 2006-01-15 Yeda Res & Dev Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
WO2006061824A2 (en) * 2004-12-06 2006-06-15 Prochon Biotech Limited Chondrocyte-based implant for the delivery of therapeutic agents
EP2514315A3 (de) * 2005-08-24 2012-11-07 Yeda Research and Development Co. Ltd. Universale von Spendern stammende tolerogene Zellen zur Induktion von nicht-syngener Transplantationstoleranz
US8921109B2 (en) 2005-09-19 2014-12-30 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US8685107B2 (en) 2007-07-03 2014-04-01 Histogenics Corporation Double-structured tissue implant and a method for preparation and use thereof
US20090054984A1 (en) 2007-08-20 2009-02-26 Histogenics Corporation Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
US8709400B2 (en) 2009-07-27 2014-04-29 Washington University Inducement of organogenetic tolerance for pancreatic xenotransplant
US20120210451A1 (en) * 2009-08-02 2012-08-16 Hirofumi Shimizu Islet cell sheet, process for production thereof, and use thereof
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804178A (en) * 1986-11-20 1998-09-08 Massachusetts Institute Of Technology Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
CA2091981A1 (en) * 1991-08-02 1993-02-03 Bruno Peault Primordial implants in immundeficient hosts
DE59410143D1 (de) * 1993-09-07 2002-08-01 Gergely Gerhard Modifizierte Kristalle einer festen, essbaren, organischen Säure
US5560911A (en) * 1993-10-12 1996-10-01 Oklahoma Medical Research Foundation Method of inhibiting acute complement mediated cytotoxicity with anti-idiotypic antibodies
US5629194A (en) * 1994-10-21 1997-05-13 Diacrin, Inc. Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity
EP1257282A4 (de) 1999-12-06 2003-05-02 Gen Hospital Corp Pankreatische stammzellen und deren verwendung in transplantation
WO2001087310A1 (en) * 2000-05-18 2001-11-22 Biotransplant, Inc. Process for reducing antibody response against xenografts
US20030031652A1 (en) * 2001-04-16 2003-02-13 Bernhard Hering Systems and methods for inducing mixed chimerism

Also Published As

Publication number Publication date
EP1487967A2 (de) 2004-12-22
US20030198628A1 (en) 2003-10-23
JP2005521497A (ja) 2005-07-21
CA2477538C (en) 2008-01-29
US20080318202A1 (en) 2008-12-25
WO2003083064A3 (en) 2004-03-25
AU2003259298A1 (en) 2003-10-13
IL164250A0 (en) 2005-12-18
US7384630B2 (en) 2008-06-10
BR0308718A (pt) 2005-01-04
AU2003259298B2 (en) 2006-08-31
DE60334534D1 (de) 2010-11-25
MXPA04009411A (es) 2005-01-25
EP1487967B1 (de) 2010-10-13
EA200401244A1 (ru) 2005-02-24
EP1487967A4 (de) 2005-05-11
CN1643133A (zh) 2005-07-20
NO20044540L (no) 2004-10-22
ZA200406983B (en) 2005-09-22
KR20040099350A (ko) 2004-11-26
WO2003083064A2 (en) 2003-10-09
CA2477538A1 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
MX2009014273A (es) Metodos y composiciones para expansion e implantacion optimizadas de celulas madre mesenquimales.
ATE382681T1 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
MXPA02007137A (es) Fuente de tejido hepatico.
WO2008048663A3 (en) Novel process for devitalized/acellular tissue for transplantation
WO2010022395A3 (en) Methods of reprogramming cells
TW200503794A (en) Treatment of tissue with undifferentiated mesenchymal cells
DE60334534D1 (de) Chimäre bauchspeicheldrüse
WO2006042238A3 (en) Methods of storing tissue matrices
WO2009050742A8 (en) Use of microvesicles (mvs) for preparing a medicament having adjuvant activity on endothelial cell transplantation, particularly in the treatment of diabetes by pancreatic islet transplantation, and related method
WO2005086860A3 (en) Methods for generating insulin-producing cells
EP1910519A4 (de) Immunphänotyp und immunogenizität menschlicher zellen aus fettgewebe
IL190693A (en) Substance damage suppressants are implanted after islet transplantation, containing and utilizing antibodies that detect il-6 receptor.
WO2004044142A3 (en) Mesenchymal stem cells and methods of use thereof
WO2003059276A3 (en) Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
DK1248640T3 (da) Xenotransplantation af svineöer og deres fremstilling
MX2021011709A (es) Celulas, tejidos y organos personalizados para trasplante de un donante humanizado, adaptado, designado libre de patogenos (no humano) y metodos y productos relacionados con estos.
WO2006113881A3 (en) Method of using stroma cells from cord blood to expand and engraft nucleated cells from cord blood
EP4545145A3 (de) Kultivierte thymusgewebetransplantation fördert die donorspezifische toleranz gegenüber allogenen festen organtransplantaten
WO2006073890A3 (en) Use of glp-1 and agonists thereof to prevent cardiac myocyte apoptosis
WO2006107850A3 (en) Preventing rejection of transplanted tissue using regulatory t cells
GB2397825B (en) Method of producing human beta cell lines
EP4257143A3 (de) Verfahren und zusammensetzungen zur behandlung von typ-1-diabetes mit fibroblasten als erleichterung der insel-transplantation
TW200833836A (en) An improved method of cultivating the Cordyceps Militaris by adding sugar cane fiber
Jang et al. Genome editing for engineering stem cell-derived pancreatic β cells: recent trends and future perspectives
SE0401807D0 (sv) Förfaranden och kompositioner för nytillväxt av kryopreserverade tallembryon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties